Literature DB >> 82131

Tiapride in Parkinson's disease.

P Price, J D Parkes, C D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 82131     DOI： 10.1016/s0140-6736(78)91850-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.

Authors:  T Norman; E Chiu; R H James; M S Gregory
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 2.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

3.  Oxpentifylline in Parkinson's disease.

Authors:  R B Godwin-Austen; J A Twomey; G Hanks; J Higgins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

4.  The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent.

Authors:  B Costall; M E Kelly; R J Naylor
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

Review 5.  Adverse effects of antiparkinsonian drugs.

Authors:  J D Parkes
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

Review 6.  Drug-induced neurological disorders.

Authors:  R J Lane; P A Routledge
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.